Healios KK Ord Shs HLOSF

Healthcare Biotechnology

Healios KK is a Japan-based company mainly engaged in business in the somatic stem cell regenerative medicine field and in the iPSC regenerative medicine field, which involves research, development and manufacture of regenerative medicine products (iPSC regenerative medicines) utilizing technologies related to induced pluripotent stem cells (iPS cells, iPSCs). The somatic stem cell regenerative medicine field develops and markets cell therapy drugs for acute stroke and acute respiratory distress syndrome using MultiStem, a somatic stem cell product for which the Company holds patent and patent licensing rights. The iPSC regenerative medicines include the creation of universal donor cells (UD), next-generation iPSCs that reduce the risk of immune rejection regardless of human leukocyte antigen (HLA) type using gene editing technology.

PINL:HLOSF - Post by User

Healios KK Ord Shs > Next Steps

<< Previous

Bullboard Posts

Next >>

Comment by waynedon Oct 06, 2011 4:23pm

218 Views

Post# 19127283

RE: Next Steps

As bad as Halo management is , Hudbay`s is a lot worse. It is a stroke of luck that it is such a prolific company that it is able to prosper despite the best efforts of it`s management to ruin it. Remember they have been able to consistently lose money at $4 plus copper . Even now they could buy Halo with it`s own cash and still have money left over , as well as the assets right outside it`s door . Dealings with either one of these companies makes my skin crawl
Maybe the way to go is to contact Pinetree .

<< Previous

Bullboard Posts

Next >>

Globex Mining: Unveiling Québec’s hidden gold and lithium treasures